Going to a free lunch sponsored by a pharmaceutical company can significantly affect a doctor’s prescription choices, a new study shows.
The study, published in JAMA Internal Medicine, found that 95 percent of the 63,524 payments from pharmaceutical companies reported by doctors in 2013 were for lunches totaling less than $18.
But the pittances spent by the drug companies were more than repaid by the doctors, who were much more likely to prescribe name-brand drugs than those who hadn’t attended pharma-provided lunches.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
